Samotolisib

• Target :

  PI3K|||DNA-PK|||Autophagy|||mTOR

• Related Pathways :

  PI3K/Akt/mTOR signaling|||DNA Damage/DNA Repair|||Autophagy

• Purity :

  0.9971

• Bioactivity :

  Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.

• Smiles :

  COC(C)Cn1c2c(cnc3ccc(cc23)-c2cncc(c2)C(C)(C)O)n(C)c1=O

• Molecular Formula :

  C23H26N4O3

• Molecular Weight :

  406.48

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1386874-06-1